[HTML][HTML] Pharmacogenomic testing: clinical evidence and implementation challenges
C Hippman, C Nislow - Journal of personalized medicine, 2019 - mdpi.com
Pharmacogenomics can enhance patient care by enabling treatments tailored to genetic
make-up and lowering risk of serious adverse events. As of June 2019, there are 132 …
make-up and lowering risk of serious adverse events. As of June 2019, there are 132 …
[HTML][HTML] Applying next-generation sequencing platforms for pharmacogenomic testing in clinical practice
Pharmacogenomics (PGx) studies the use of genetic data to optimize drug therapy.
Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical …
Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical …
[HTML][HTML] Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
M Mukaka, MA Onyamboko, P Olupot-Olupot… - …, 2023 - thelancet.com
Background There are no pharmacokinetic data of single low dose primaquine (SLDPQ) as
transmission blocking in African children with acute Plasmodium falciparum and glucose-6 …
transmission blocking in African children with acute Plasmodium falciparum and glucose-6 …
AmpliChip CYP450 test: personalized medicine has arrived in psychiatry
J De Leon - Expert review of molecular diagnostics, 2006 - Taylor & Francis
The US FDA has granted market approval for the first pharmacogenetic test using a DNA
microarray, the AmpliChip CYP450, which genotypes cytochrome P450 (CYP) 2D6 and …
microarray, the AmpliChip CYP450, which genotypes cytochrome P450 (CYP) 2D6 and …
CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans
CYP2D6 genotype and debrisoquine metabolic ratio (MR) were analyzed in 133
Nicaraguan Mestizos (NMs) and 260 Cubans divided into Cuban Mestizos (CMs) and White …
Nicaraguan Mestizos (NMs) and 260 Cubans divided into Cuban Mestizos (CMs) and White …
Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF …
MEG Naranjo, F Rodrigues-Soares… - Omics: a journal of …, 2018 - liebertpub.com
Abstract Pharmacogenetic variation in Latin Americans is understudied, which sets a barrier
for the goal of global precision medicine. The RIBEF-CEIBA Network Consortium was …
for the goal of global precision medicine. The RIBEF-CEIBA Network Consortium was …
[HTML][HTML] Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences
J Muriel, J Barrachina, G Del Barco… - Frontiers in …, 2023 - frontiersin.org
Introduction: Opioid deprescription is the process of supervised tapering and safe
withdrawal when a potentially inappropriate use is detected. This represents a challenge in …
withdrawal when a potentially inappropriate use is detected. This represents a challenge in …
Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity
Debrisoquine hydroxylation polymorphism is by far the most thoroughly studied genetic
polymorphism of the CYP2D6 drug-metabolizing enzyme. Debrisoquine hydroxylation …
polymorphism of the CYP2D6 drug-metabolizing enzyme. Debrisoquine hydroxylation …
Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers
I González, EM Peñas-Lledó, B Pérez… - …, 2008 - Taylor & Francis
Objectives: Our group has previously show that interindividual variability in CYP2D6
hydroxylation capacity was related to personality differences in cognitive social anxiety …
hydroxylation capacity was related to personality differences in cognitive social anxiety …
To genotype or phenotype for personalized medicine? CYP450 drug metabolizing enzyme genotype–phenotype concordance and discordance in the Ecuadorian …
F De Andrés, S Terán, F Hernández… - Omics: a journal of …, 2016 - liebertpub.com
Genetic variations within the cytochrome P450 (CYP450) superfamily of drug metabolizing
enzymes confer substantial person-to-person and between-population differences in …
enzymes confer substantial person-to-person and between-population differences in …